March 28 (Reuters) - CG Oncology Inc CGON.O:
CG ONCOLOGY REPORTS 2024 YEAR END FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES
CG ONCOLOGY INC: QTRLY LOSS PER SHARE $0.46
Source text: ID:nGNXbvgS0k
Further company coverage: CGON.O
((Reuters.Briefs@thomsonreuters.com;))